Amivantamab
Catalogue number:
HY-P9977-1mg
Supplier:
Size:
1 mg
Product is available in:
Applications:
Cancer-programmed cell death
Target:
EGFR
Alternative Names:
JNJ-61186372
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells[1].